Reviving Clinical Research: The UK CTR and a New Era for Innovation

The UK’s Clinical Trials Regulation (CTR), signed into law in April 2025, aims to foster innovation, accelerate approvals, and enable patient participation in research while safeguarding their safety and rights. Supporting innovation is a key priority for the Medicines and Healthcare products Regulatory Agency (MHRA), particularly as the UK has experienced a steady decline in […]